Alfred University, Himed partner to research biomaterials used in hard tissue replacement
Alfred University’s New York State College of Ceramics (NYSCC) today announced the signing of a collaborative research agreement with Himed, a global provider of high-quality biomaterials, to understand and optimize the synthesis and processing of biomaterials used for hard tissue replacement applications. The partnership supports Governor Andrew M. Cuomo’s university-led approach to regional economic development.
ALFRED, NY—Alfred University’s New York State College of Ceramics (NYSCC) today announced the signing of a collaborative research agreement with Himed, a global provider of high-quality biomaterials, to understand and optimize the synthesis and processing of biomaterials used for hard tissue replacement applications. The partnership supports Governor Andrew M. Cuomo’s university-led approach to regional economic development.
Hard tissues include bone and tooth structures that are well suited for biocompatible ceramic materials. As the global population continues to age, the repair and replacement of hard tissues represents hundreds of billions in costs annually. The research agreement with the NYSCC will allow Himed to continue its role of supplying this vital sector and potentially enter new and expanding markets, supporting the growth of New York State’s biomaterials sector.
Founded in 1991, Himed is a leader in the development of biomaterial coating technologies that have greatly improved the efficacy of materials used in the medical, dental, laboratory and research industries. The company has a global market with clients in North and South America, Europe, East and West Asia, and North Africa. Their cutting-edge facilities offer extensive, unique capabilities for the production of raw biomaterials, as well as providing customizable biocompatible coating and texturing solutions, which are of particular importance for hard tissue replacement.
Alfred University’s Center for High Temperature Characterization (CHTC) at the College of Ceramics will conduct research on powder characterization, specifically heat treatments and materials characterization to optimize not only the physical shape and size of Himed’s powders, but also their surface and bulk chemical and physical configuration at the nanoscale. The CHTC, established with a $4 million investment from New York State, provides access to an unmatched suite of high temperature characterization equipment supporting the growth of the advanced materials industry.
The CHTC’s work with industry is supported through Alfred’s Center for Advanced Ceramic Technology (CACT), one of fifteen NYSTAR Centers for Advanced Technology (CAT) located around the State. Alfred’s CACT has worked to support the growth of the State’s ceramic and glass industry for over three decades, providing not only access to the University’s technical infrastructure, but also by providing cost-share in support of research projects with New York State firms seeking solutions to difficult materials challenges.
“This project illustrates how Alfred’s unique skillset in examining these kinds of biocompatible materials can not only lead to significant improvements in performance, but also in supporting the growth of companies here in New York State,” said Scott Misture, the lead researcher at Alfred University working in support of the program with Himed.
“The opportunity to work with Himed also provides students with valuable experience in understanding how these characterization technologies can positively impact real-world materials challenges," Misture added.
At the conclusion of this initial phase, it is anticipated that both organizations will seek future opportunities to conduct research in biocompatible materials and coatings.
“We’re very excited to start this new collaboration with Alfred University and to work closely with the brilliant team of professors and students in their ceramics group,” said Dana Barnard, CEO of Himed. “It’s a terrific opportunity for a New York company to collaborate with a New York university and help advance biomaterial research in the State of New York. Himed has a global clientele, and we expect that this collaboration will help us provide even more bioactive materials that help the body heal to our partners around the world.”